3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Leukemia
16
Burkitt Lymphoma
12
Lymphoma
6
Leukemia, Biphenotypic, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myeloid, Acute
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Erythroblastic, Acute
1
Leukemia, B-Cell
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Cyclophosphamide
13
Etoposide
10
Prednisone
8
Doxorubicin
8
Whole-Body Irradiation
7
Vincristine
7
Rituximab
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Brentuximab Vedotin
7
romidepsin
6
fludarabine phosphate
6
Mycophenolic Acid
6
fludarabine
5
Lenalidomide
5
Gemcitabine
5
Cytarabine
5
10-propargyl-10-deazaaminopterin
5
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Carmustine
4
Busulfan
4
Antilymphocyte Serum
4
pembrolizumab
3
etoposide phosphate
3
carmustine, poliferprosan 20 drug combination
3
Vorinostat
3
Sirolimus
3
Nivolumab
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell
×
Mercaptopurine
×
Clear all
No trials found.